Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	250.84M +62.9%
Revenue (ttm)	115.75M +36.1%
Net Income	20.17M +58.0%
EPS	0.03 +58.0%
Shares Out	581.33M
PE Ratio	12.62
Forward PE	10.53
Dividend	0.01 (1.52%)
Ex-Dividend Date	May 28, 2026

Volume	37,319
Open	0.5760
Previous Close	0.5600
Day's Range	0.5500 - 0.5780
52-Week Range	0.3200 - 0.8350
Beta	0.38
Analysts	Buy
Price Target	0.83 (+43.6%)
Earnings Date	Sep 2, 2026

About LON:IDHC

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroe...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 7,137
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2025, LON:IDHC's revenue was 7.86 billion, an increase of 37.34% compared to the previous year's 5.72 billion. Earnings were 1.26 billion, an increase of 17.15%.

Financial numbers in EGP

Analyst Summary

According to 2 analysts, the average rating for IDHC stock is "Buy." The 12-month stock price target is $0.83, which is an increase of 43.60% from the latest price.

Price Target

$0.83

(43.60% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 17, 2026

Data Sources Report a data error